» Articles » PMID: 34879801

The Alzheimer's Disease Amyloid Precursor Protein and Its Neuritogenic Actions

Overview
Specialty Neurology
Date 2021 Dec 9
PMID 34879801
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The Amyloid Precursor Protein (APP) is principally known and studied for its involvement in Alzheimer's disease as the source of the amyloid β peptide; however, its physiological actions within the nervous system are also important as it is involved in a range of neuronal activities, including neurogenesis, synaptic plasticity, neurite outgrowth, and neuroprotection. Of the different neuronal functions that APP can affect, some may be relevant to APP's role in Alzheimer's disease, while others can be primarily related to its physiological roles. This review will focus on APP's neuritogenic actions and surmise the key molecular mechanisms, as well as the structural and signaling requirements, which form the basis for APP's neuritogenic effects. Deciphering the normal function(s) of APP is valuable to properly understanding its role in health as well as Alzheimer's disease.

Citing Articles

Gut Microbiota Mediates Neuroinflammation in Alzheimer's Disease: Unraveling Key Factors and Mechanistic Insights.

Junyi L, Yueyang W, Bin L, Xiaohong D, Wenhui C, Ning Z Mol Neurobiol. 2024; 62(3):3746-3763.

PMID: 39317889 DOI: 10.1007/s12035-024-04513-w.


APPlications of amyloid-β precursor protein metabolites in macrocephaly and autism spectrum disorder.

Sokol D, Lahiri D Front Mol Neurosci. 2023; 16:1201744.

PMID: 37799731 PMC: 10548831. DOI: 10.3389/fnmol.2023.1201744.


Agent Orange Causes Metabolic Dysfunction and Molecular Pathology Reminiscent of Alzheimer's Disease.

de la Monte S, Goel A, Tong M, Delikkaya B J Alzheimers Dis Rep. 2023; 7(1):751-766.

PMID: 37662613 PMC: 10473158. DOI: 10.3233/ADR-230046.


Amyloid Precursor Protein (APP) Regulates Gliogenesis and Neurogenesis of Human Neural Stem Cells by Several Signaling Pathways.

Coronel R, Bernabeu-Zornoza A, Palmer C, Gonzalez-Sastre R, Rosca A, Mateos-Martinez P Int J Mol Sci. 2023; 24(16).

PMID: 37629148 PMC: 10455174. DOI: 10.3390/ijms241612964.


Metabolomic Footprint of Disrupted Energetics and Amino Acid Metabolism in Neurodegenerative Diseases: Perspectives for Early Diagnosis and Monitoring of Therapy.

Maszka P, Kwasniak-Butowska M, Cysewski D, Slawek J, Smolenski R, Tomczyk M Metabolites. 2023; 13(3).

PMID: 36984809 PMC: 10057046. DOI: 10.3390/metabo13030369.